J. Bell

发表

Early Dissemination of NDM-1- and OXA-181-Producing Enterobacteriaceae in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007

Ronald N. Jones, M. Castanheira, D. Mathai, 2010, Antimicrobial Agents and Chemotherapy.

Australian Group on Antimicrobial Resistance Hospital-onset Staphylococcus aureus Surveillance Programme annual report, 2011.

J. Turnidge, P. Collignon, M. McLaws, 2013, Communicable diseases intelligence quarterly report.

Genetic Diversity among Community Methicillin-Resistant Staphylococcus aureus Strains Causing Outpatient Infections in Australia

P. Giffard, G. Nimmo, J. Pearson, 2004, Journal of Clinical Microbiology.

Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the Community

John D. Turnidge, J. Turnidge, F. Tenover, 2002, Journal of Clinical Microbiology.

Fusidic Acid Resistance Rates and Prevalence of Resistance Mechanisms among Staphylococcus spp. Isolated in North America and Australia, 2007-2008

Ronald N. Jones, M. Castanheira, J. Turnidge, 2010, Antimicrobial Agents and Chemotherapy.

“Down the drain”: carbapenem‐resistant bacteria in intensive care unit patients and handwashing sinks

L. Wright, E. Gillespie, T. Korman, 2013, The Medical journal of Australia.

Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).

Ronald N. Jones, J. Turnidge, S. Kamihira, 2005, Diagnostic microbiology and infectious disease.

Minim Typing – A Rapid and Low Cost MLST Based Typing Tool for Klebsiella pneumoniae

S. Tong, J. Turnidge, P. Giffard, 2012, PloS one.

Selection of SHV Extended-Spectrum-β-Lactamase-Dependent Cefotaxime and Ceftazidime Resistance in Klebsiella pneumoniae Requires a Plasmid-Borne blaSHV Gene

D. S. Hammond, J. Turnidge, T. Harris, 2007, Antimicrobial Agents and Chemotherapy.

Prevalence and Significance of a Negative Extended-Spectrum β-Lactamase (ESBL) Confirmation Test Result after a Positive ESBL Screening Test Result for Isolates of Escherichia coli and Klebsiella pneumoniae: Results from the SENTRY Asia-Pacific Surveillance Program

Ronald N. Jones, J. Turnidge, M. Barton, 2007, Journal of Clinical Microbiology.

Prevalence of Extended-Spectrum β-Lactamase-Producing Enterobacter cloacae in the Asia-Pacific Region: Results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001

R. Jones, J. Bell, J. Turnidge, 2003, Antimicrobial Agents and Chemotherapy.

Changing patterns in gonococcal infection in Australia, 1981‐1987 Australian Gonococcal Surveillance Programme

M. Peel, J. Bates, K. Withnall, 1988, The Medical journal of Australia.

Rapidly emerging antimicrobial resistances in Streptococcus pneumoniae in Australia

J. Turnidge, P. Collignon, J. Bell, 1999, The Medical journal of Australia.

Inactivation, removal, and regrowth potential of opportunistic pathogens and antimicrobial resistance genes in recycled water systems.

J. Turnidge, M. Short, Paul Monis, 2021, Water research.

Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2015.

J. Turnidge, J. Bell, G. Coombs, 2018, Communicable diseases intelligence.

Australian Group on Antimicrobial Resistance Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2014.

J. Turnidge, P. Collignon, B. Howden, 2016, Communicable diseases intelligence quarterly report.

Antimicrobial susceptibility of Staphylococcus aureus isolated from hospital inpatients, 2009: report from the Australian Group on Antimicrobial Resistance.

P. Collignon, M. McLaws, G. Nimmo, 2011, Communicable diseases intelligence quarterly report.

Development of a Disk Diffusion Method for Testing Moraxella catarrhalis Susceptibility Using Clinical and Laboratory Standards Institute Methods: a SENTRY Antimicrobial Surveillance Program Report

Ronald N. Jones, J. Turnidge, J. Bell, 2009, Journal of Clinical Microbiology.

Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Sepsis Outcome Programme(AESOP) Annual Report 2015.

J. Turnidge, J. Bell, G. Coombs, 2018, Communicable diseases intelligence.

Australian Group on Antimicrobial Resistance Australian Enterococcal Sepsis Outcome Programme annual report, 2014.

J. Turnidge, Paul D. R. Johnson, D. Kotsanas, 2016, Communicable diseases intelligence quarterly report.

Dissemination and genetic context analysis of bla(VIM-6) among Pseudomonas aeruginosa isolates in Asian-Pacific Nations.

M. Castanheira, R. Jones, J. Bell, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Carbapenem Resistance among Pseudomonas aeruginosa Strains from India: Evidence for Nationwide Endemicity of Multiple Metallo-β-Lactamase Clones (VIM-2, -5, -6, and -11 and the Newly Characterized VIM-18)

Ronald N. Jones, M. Castanheira, J. Turnidge, 2008, Antimicrobial Agents and Chemotherapy.

Emergence of Carbapenem Resistance in Acinetobacter baumannii Recovered From Blood Cultures in Australia

A. Peleg, D. Spelman, J. Bell, 2006, Infection Control & Hospital Epidemiology.

Identification of bla(CMY-7) and associated plasmid-mediated resistance genes in multidrug-resistant Escherichia coli isolated from dogs at a veterinary teaching hospital in Australia.

D. Trott, H. W. Stokes, N. Hanson, 2006, The Journal of antimicrobial chemotherapy.

SENTRY Antimicrobial Surveillance Program Asia-Pacific region and South Africa.

J. Turnidge, J. Bell, 2003, Communicable diseases intelligence quarterly report.

Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GnSOP) Annual Report 2020.

J. Iredell, S. Partridge, T. Gottlieb, 2022, Communicable diseases intelligence.

Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2019.

J. Iredell, S. Partridge, T. Gottlieb, 2020, Communicable diseases intelligence.

Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2018.

T. Gottlieb, J. Bell, G. Coombs, 2020, Communicable diseases intelligence.

Antimicrobial Susceptibility of Escherichia coli and Salmonella spp. Isolates From Healthy Pigs in Australia: Results of a Pilot National Survey

M. O'Dea, C. McDevitt, D. Trott, 2018, Front. Microbiol..

Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756.

R. Jones, J. Bell, J. Turnidge, 2002, International journal of antimicrobial agents.

Plasmid-borne blaSHV genes in Klebsiella pneumoniae are associated with strong promoters.

J. Turnidge, M. Turner, T. Harris, 2009, The Journal of antimicrobial chemotherapy.

Methicillin-resistant Staphylococcal aureus evolution in Australia over 35 years.

J. Bell, J. Turnidge, 2000, Microbial drug resistance.

In Vitro Activities of Ertapenem (MK-0826) against Recent Clinical Bacteria Collected in Europe and Australia

F. Baquero, R. Zbinden, H. Endtz, 2001, Antimicrobial Agents and Chemotherapy.

Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99).

Ronald N. Jones, J. Turnidge, M. Pfaller, 2002, Diagnostic microbiology and infectious disease.

High Prevalence of Oxacillin-Resistant Staphylococcus aureus Isolates from Hospitalized Patients in Asia-Pacific and South Africa: Results from SENTRY Antimicrobial Surveillance Program, 1998-1999

J. Turnidge, J. Bell, 2002, Antimicrobial Agents and Chemotherapy.

Genetic Diversity among Community Methicillin-Resistant Staphylococcus aureus Strains Causing Outpatient Infections in Australia Antimicrobial Resistance†

P. Giffard, G. Nimmo, J. Pearson, 2004 .

Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.

Ronald N. Jones, J. Turnidge, I. Kobayashi, 2009, Diagnostic microbiology and infectious disease.

Prevalence of antimicrobial resistances in Streptococcus pneumoniae in Australia, 2005: report from the Australian Group on Antimicrobial Resistance.

P. Collignon, J. Robson, T. Gottlieb, 2008, Communicable diseases intelligence quarterly report.

VanD-Type Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis

P. Courvalin, F. Depardieu, J. Bell, 2004, Antimicrobial Agents and Chemotherapy.

In vitro assessment of gatifloxacin spectrum and potency tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from the Asia-Western Pacific component of the SENTRY antimicrobial surveillance program (1998-1999).

Ronald N. Jones, J. Turnidge, M. Pfaller, 2002, Diagnostic microbiology and infectious disease.

Emergence of IMP-4 metallo-β-lactamase in a clinical isolate from Australia

A. Peleg, D. Spelman, J. Bell, 2004 .

Emergence of IMP-4 metallo-beta-lactamase in a clinical isolate from Australia.

A. Peleg, D. Spelman, J. Bell, 2004, The Journal of antimicrobial chemotherapy.

Evaluation of the contemporary occurrence rates of metallo-beta-lactamases in multidrug-resistant Gram-negative bacilli in Japan: report from the SENTRY Antimicrobial Surveillance Program (1998-2002).

Ronald N. Jones, J. Turnidge, Y. Hirakata, 2004, Diagnostic microbiology and infectious disease.

Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations.

J. Turnidge, D. Peckham, J. Bell, 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals, 1989-1999.

J. Turnidge, I. Gosbell, D. Mitchell, 2003, Microbial drug resistance.

Genetic and Biochemical Characterization of an Acquired Subgroup B3 Metallo-β-Lactamase Gene, blaAIM-1, and Its Unique Genetic Context in Pseudomonas aeruginosa from Australia

M. Toleman, D. Yong, T. Walsh, 2012, Antimicrobial Agents and Chemotherapy.

Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.

Ronald N. Jones, M. Castanheira, J. Turnidge, 2008, The Journal of antimicrobial chemotherapy.

Improved Synthesis of Biotinol-5'-AMP: Implications for Antibacterial Discovery.

R. Lumb, G. Booker, J. Turnidge, 2015, ACS medicinal chemistry letters.

Absence of high priority critically important antimicrobial resistance in Salmonella sp. isolated from Australian commercial egg layer environments.

M. O'Dea, M. Valcanis, C. McDevitt, 2021, International journal of food microbiology.

Superbugs in the supermarket? Assessing the rate of contamination with third-generation cephalosporin-resistant gram-negative bacteria in fresh Australian pork and chicken

M. Barton, M. Grayson, S. Ballard, 2018, Antimicrobial Resistance & Infection Control.

Inter-country transfer of Gram-negative organisms carrying the VIM-4 and OXA-58 carbapenem-hydrolysing enzymes.

A. Hofmeyr, A. Peleg, J. Bell, 2006, The Journal of antimicrobial chemotherapy.

Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999.

Ronald N. Jones, J. Turnidge, D. Biedenbach, 2002, International journal of antimicrobial agents.

Multiply resistant Streptococcus pneumoniae infection

P. Collignon, J. Bell, 1993 .

Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia.

A. Peleg, D. Spelman, J. Bell, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Genetic Characterization of vanG, a Novel Vancomycin Resistance Locus of Enterococcus faecalis

J. Turnidge, J. Paton, A. M. Berry, 2000, Antimicrobial Agents and Chemotherapy.

Drug‐resistant Streptococcus pneumoniae: the beginning of the end for many antibiotics?

P. Collignon, J. Bell, 1996, The Medical journal of Australia.

A national collaborative study of resistance to antimicrobial agents in Haenwphilus influenzae in Australian hospitals

P. Collignon, G. Gilbert, J. Bell, 1992 .

Activities of Dalbavancin against a Worldwide Collection of 81,673 Gram-Positive Bacterial Isolates

Ronald N. Jones, J. Turnidge, H. Sader, 2009, Antimicrobial Agents and Chemotherapy.

Performance of Phenotypic Tests for Detection of Penicillinase in Staphylococcus aureus Isolates from Australia

I. Bastian, L. Papanicolas, J. Bell, 2014, Journal of Clinical Microbiology.

Antimicrobial Activities of Garenoxacin (BMS 284756) against Asia-Pacific Region Clinical Isolates from the SENTRY Program, 1999 to 2001

R. Jones, K. Christiansen, J. Bell, 2004, Antimicrobial Agents and Chemotherapy.

Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents.

J. Turnidge, P. Rhomberg, H. Sader, 2009, Diagnostic microbiology and infectious disease.

Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific.

Ronald N. Jones, J. Turnidge, J. Bell, 2003, The Journal of antimicrobial chemotherapy.

Prevalence of antimicrobial resistance in Enterococcus isolates in Australia, 2005: report from the Australian Group on Antimicrobial Resistance.

J. Turnidge, J. Pearson, K. Christiansen, 2007, Communicable diseases intelligence quarterly report.

OXA-58 and IMP-4 Carbapenem-Hydrolyzing β-Lactamases in an Acinetobacter junii Blood Culture Isolate from Australia

A. Peleg, D. Spelman, J. Bell, 2006, Antimicrobial Agents and Chemotherapy.

Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme.

J. Turnidge, J. Li, R. Nation, 2009, The Journal of infection.

Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR

Torsten Seemann, Wei Gao, Benjamin P. Howden, 2011, PLoS pathogens.

Phylogenetic diversity, antimicrobial susceptibility and virulence characteristics of phylogroup F Escherichia coli in Australia.

J. Turnidge, P. Collignon, D. Trott, 2016, Microbiology.

Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).

Ronald N. Jones, J. Turnidge, T. Fritsche, 2007, International journal of antimicrobial agents.

In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae.

J. Turnidge, J. Li, R. Nation, 2008, The Journal of antimicrobial chemotherapy.

Australian Group on Antimicrobial Resistance Community-onset Gram-negative Surveillance Program annual report, 2010.

J. Turnidge, T. Gottlieb, J. Pearson, 2013, Communicable diseases intelligence quarterly report.

Emergence of Vancomycin-Resistant Enterococci in Australia: Phenotypic and Genotypic Characteristics of Isolates

J. Turnidge, J. Paton, J. Bell, 1998, Journal of Clinical Microbiology.

MULTICENTRE STUDY OF THE IN VITRO ACTIVITY OF CEFEPIME, A BROAD‐SPECTRUM CEPHALOSPORIN, COMPARED TO OTHER BROAD‐SPECTRUM AGENTS

J. Turnidge, J. Bell, 2001, Pathology.

Antimicrobial resistance testing of Helicobacter pylori: A comparison of etest and disk diffusion methods

J. Turnidge, L. Grayson, P. Midolo, 1997, Pathology.

VanE-Type Vancomycin-Resistant Enterococcus faecalis Clinical Isolates from Australia

P. Courvalin, B. Périchon, Lorena Abadía-Patiño, 2004, Antimicrobial Agents and Chemotherapy.

Prevalence of antimicrobial resistances in common pathogenic Enterobacteriaceae in Australia, 2004: report from the Australian Group on Antimicrobial Resistance.

J. Turnidge, J. Pearson, J. Bell, 2007, Communicable diseases intelligence quarterly report.

Community-onset Gram-negative Surveillance Program annual report, 2012.

J. Turnidge, T. Gottlieb, J. Bell, 2014, Communicable diseases intelligence quarterly report.

Superbugs in the supermarket? Assessing the rate of contamination with third-generation cephalosporin-resistant gram-negative bacteria in fresh Australian pork and chicken

M. Barton, M. Grayson, S. Ballard, 2018, Antimicrobial Resistance and Infection Control.

Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme(GNSOP) Annual Report 2015.

T. Gottlieb, J. Bell, G. Coombs, 2018, Communicable diseases intelligence.

Australian Group on Antimicrobial Resistance Australian Enterobacteriaceae Sepsis Outcome Programme annual report, 2014.

J. Turnidge, J. Robson, T. Gottlieb, 2016, Communicable diseases intelligence quarterly report.

Enterobacteriaceae Sepsis Outcome Programme annual report, 2013.

J. Turnidge, T. Gottlieb, J. Bell, 2014, Communicable diseases intelligence quarterly report.

Hospital-onset Gram-negative Surveillance Program annual report, 2011.

J. Turnidge, T. Gottlieb, J. Pearson, 2014, Communicable diseases intelligence quarterly report.

Regional Resistance Surveillance Program Results for 12 Asia-Pacific Nations (2011)

Ronald N. Jones, M. Castanheira, J. Turnidge, 2013, Antimicrobial Agents and Chemotherapy.

Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.

J. Turnidge, G. Gilbert, V. Krause, 2003, Communicable diseases intelligence quarterly report.

Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia.

Ronald N. Jones, J. Turnidge, D. Biedenbach, 2006, Diagnostic microbiology and infectious disease.

The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008).

Ronald N. Jones, J. Turnidge, D. Farrell, 2010, The Journal of infection.

Regional Resistance Surveillance Program Results for

M. Castanheira, J. Turnidge, R. Mendes, 2013 .

Antimicrobial susceptibility of Staphylococcus aureus and molecular epidemiology of meticillin-resistant S. aureus isolated from Australian hospital inpatients: Report from the Australian Group on Antimicrobial Resistance 2011 Staphylococcus aureus Surveillance Programme.

J. Turnidge, P. Collignon, M. McLaws, 2013, Journal of global antimicrobial resistance.

In vitro potency of doripenem tested against an international collection of rarely isolated bacterial pathogens.

Ronald N. Jones, J. Turnidge, H. Sader, 2009, Diagnostic microbiology and infectious disease.

Codetection of blaOXA-23-Like Gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: Report from the SENTRY Antimicrobial Surveillance Program

Ronald N. Jones, M. Castanheira, J. Turnidge, 2008, Antimicrobial Agents and Chemotherapy.

Prevalence of MRSA strains among Staphylococcus aureus isolated from outpatients, 2006.

P. Collignon, M. McLaws, G. Nimmo, 2009, Communicable diseases intelligence quarterly report.

A risk for returned travellers: the “post‐antibiotic era”

P. Collignon, J. Bell, Geethanie A T P Fernando, 2010, The Medical journal of Australia.

Biotin analogues with antibacterial activity are potent inhibitors of biotin protein ligase.

G. Booker, J. Turnidge, M. Wilce, 2012, ACS medicinal chemistry letters.

Prevalence of MRSA among Staphylococcus aureus isolated from hospital inpatients, 2005: report from the Australian Group for Antimicrobial Resistance.

P. Collignon, M. McLaws, G. Nimmo, 2007, Communicable diseases intelligence quarterly report.

Fifteen years of surveillance by the Australian Group for Antimicrobial Resistance (AGAR).

Graeme R Nimmo, Peter J Collignon, P. Collignon, 2003, Communicable diseases intelligence quarterly report.

Worldwide distribution and environmental origin of the Adelaide imipenemase (AIM-1), a potent carbapenemase in Pseudomonas aeruginosa

J. Turnidge, H. Venter, J. Bell, 2021, Microbial genomics.

Carbapenem-Resistant Isolates of Klebsiella pneumoniae in China and Detection of a Conjugative Plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 Gene

Ronald N. Jones, J. Turnidge, Ziyong Sun, 2007, Antimicrobial Agents and Chemotherapy.

, aeruginosa from Australia Genetic Context in Pseudomonas , and Its UniqueAIM-1 bla-Lactamase Gene , β of an Acquired Subgroup B 3 Metallo-Genetic and Biochemical Characterization

M. Toleman, D. Yong, T. Walsh, 2012 .

Identification of plasmid-mediated extended-spectrum and AmpC beta-lactamases in Enterobacter spp. isolated from dogs.

D. Trott, N. Hanson, H. Sidjabat, 2007, Journal of Medical Microbiology.

New Combinations of Mutations in VanD-Type Vancomycin-Resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium Strains

J. Lavigne, P. Courvalin, F. Depardieu, 2009, Antimicrobial Agents and Chemotherapy.

Progress towards a coordinated, national paediatric antimicrobial resistance surveillance programme: Staphylococcus aureus, enterococcal and Gram-negative bacteraemia in Australia.

J. Carapetis, A. Bowen, C. Blyth, 2020, The Journal of antimicrobial chemotherapy.

Prevalence and Signiﬁcance of a Negative Extended-Spectrum (cid:2) -Lactamase (ESBL) Conﬁrmation Test Result after a Positive ESBL Screening Test Result for Isolates of Escherichia coli and Klebsiella pneumoniae : Results from the SENTRY Asia-Paciﬁc Surveillance Program (cid:1)

Ronald N. Jones, J. Turnidge, M. Barton, 2007 .

Invasive Haemophilus influenzae infection in the Australian Capital Territory region

P. Collignon, J. Bell, A. Mcgregor, 1992, The Medical journal of Australia.

Meningitis caused by a penicillin‐ and chloramphenicol‐resistant Streptococcus pneumoniae

P. Collignon, J. Bell, D. Mitchell, 1988, The Medical journal of Australia.

Australian Group on Antimicrobial Resistance Enterococcus Surveillance Programme annual report, 2010.

J. Turnidge, T. Gottlieb, J. Pearson, 2013, Communicable diseases intelligence quarterly report.

Prevalence of MRSA strains among Staphylococcus aureus isolated from outpatients, 2006.

P. Collignon, M. McLaws, G. Nimmo, 2009, Communicable diseases intelligence quarterly report.

Antimicrobial susceptibility of Staphylococcus aureus isolated from hospital inpatients, 2009: report from the Australian Group on Antimicrobial Resistance.

P. Collignon, M. McLaws, G. Nimmo, 2011, Communicable diseases intelligence quarterly report.

A national collaborative study of resistance to antimicrobial agents in Haemophilus influenzae in Australian hospitals. The Australian Group for Antimicrobial Resistance (AGAR).

P. Collignon, G. Gilbert, J. Bell, 1992, The Journal of antimicrobial chemotherapy.

Validation of a modified Kirby-Bauer disk diffusion method for metronidazole susceptibility testing of Helicobacter pylori.

J. Turnidge, P. Midolo, J. Bell, 1995, Diagnostic microbiology and infectious disease.

Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2015.

J. Turnidge, J. Bell, G. Coombs, 2018, Communicable diseases intelligence.

Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Sepsis Outcome Programme(AESOP) Annual Report 2015.

J. Turnidge, J. Bell, G. Coombs, 2018, Communicable diseases intelligence.

Performance of Phenotypic Tests for Detection of Penicillinase in Staphylococcus aureus Isolates from Australia

I. Bastian, L. Papanicolas, J. Bell, 2014, Journal of Clinical Microbiology.

Activity of daptomycin against gram-positive bacterial isolates from Indian medical centres (2006-2007).

Ronald N. Jones, J. Turnidge, D. Mathai, 2009, International journal of antimicrobial agents.

Phylogenetic diversity, antimicrobial susceptibility and virulence characteristics of phylogroup F Escherichia coli in Australia.

J. Turnidge, P. Collignon, D. Trott, 2016, Microbiology.

Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2017.

T. Gottlieb, J. Bell, G. Coombs, 2019, Communicable diseases intelligence.

Prevalence of antimicrobial resistances in common pathogenic Enterobacteriaceae in Australia, 2004: report from the Australian Group on Antimicrobial Resistance.

J. Pearson, J. Bell, John D. Turnidge, 2007, Communicable diseases intelligence quarterly report.

J. Verhoef, M. Pfaller, G. Doern, 2000, Microbial drug resistance.

Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2016.

T. Gottlieb, J. Bell, G. Coombs, 2018, Communicable diseases intelligence.

Outbreak of Invasive Methicillin-Resistant Staphylococcus aureus Infection Associated With Acupuncture and Joint Injection

R. Murray, D. Speers, J. Pearson, 2008, Infection Control & Hospital Epidemiology.